Human Papillomavirus (HPV) Infection Recruiting Phase 2 Trials for Human papillomavirus type 16 L1 capsid protein antigen (DB10301)

Back to Human Papillomavirus (HPV) Infection

Also known as: Human Papillomavirus Infections / Human Papilloma Virus Infection / Human Papillomavirus Infection / Human Papillomavirus (HPV) Infections / HPV infection / Human papillomavirus infection (disorder) / Papillomavirus Infections / Disease caused by Papillomavirus (disorder) / Papilloma viral infection / Papilloma viral infection NOS / Papilloma viral infections

Indication	Status	Phase
DBCOND0032819 (Human Papillomavirus (HPV) Infection)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05334706	A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)	Prevention	Human papillomavirus type 11 L1 capsid protein antigen (DB10300) Human papillomavirus type 16 L1 capsid protein antigen (DB10301) Human papillomavirus type 18 L1 capsid protein antigen (DB10302) Human papillomavirus type 31 L1 capsid protein antigen (DB10310) Human papillomavirus type 33 L1 capsid protein antigen (DB10311) Human papillomavirus type 45 L1 capsid protein antigen (DB10312) Human papillomavirus type 52 L1 capsid protein antigen (DB10313) Human papillomavirus type 58 L1 capsid protein antigen (DB10314) Human papillomavirus type 6 L1 capsid protein antigen (DB10299)